Lite Strategy, Inc.
$1.43
-3.5%Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
At a Glance
Live SnapshotIntrinsic Alpha Methodology
Thesis Lenses
Signal
Medium confidenceValuation multiple is compressed (P/E -1.9).
Valuation inputs: P/E -1.9, earnings yield N/A, momentum -3.5%.
If multiples stay elevated while momentum fades, downside repricing risk rises.
Driver
High confidenceReturn profile is soft (ROE -94.2%, ROIC -1.0%).
Profitability stack: net margin 0.0%, ROE -94.2%, ROIC -1.0%.
Quality deterioration often appears in margins before it shows up in headline EPS.
Risk
High confidenceRisk profile is balanced but has notable pressure points to monitor.
Risk factors: liabilities/assets +7.4%, momentum -3.5%, net margin 0.0%.
Higher leverage with weak momentum and thin margins can amplify drawdown severity.
Lite Strategy, Inc. Market vs Earnings Trajectory
Loading price and EPS data...
Lite Strategy, Inc. Fair Value Envelope
Lite Strategy, Inc. Profit Bridge
Profitability Analysis
Lite Strategy, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Cash Flow Quality Insight
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
Lite Strategy, Inc. Funding & Solvency Profile
Financial Health Analysis
Current Ratio
Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.
Debt-to-Equity Ratio
Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.
Working Capital
Strong working capital position provides significant operational flexibility and financial cushion.
Asset Composition
Capital-intensive business with significant long-term investments in property, equipment, or intangibles.
Financial Health Insight
Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.
Lite Strategy, Inc. Street Expectations Map
No Target Data
No analyst price targets available for lits.
Lite Strategy, Inc. Insider Positioning
During the last 12 months, insiders have purchased $172K and sold $946K worth of LITS shares, resulting in $775K of net selling activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
70.0K
97.70K
690.6K
946.14K
-848K
-$848K
6-9 Months
32.1K
73.81K
0
0.00
+74K
+$74K
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
Flynn James P
Director
$146K
Lee Charles Benjamin
Director
$26K
Top Sellers
Schornstein Alexander
10 Percent Owner
$946K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $775K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Insider Participation
2 insider buyers vs. 1 sellers. More insiders buying than selling indicates positive sentiment.
lits Dividend History
Learning Layer
Related Guides
Build conviction on LITS by pairing this stock hub with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.